Beyond dopamine: Further evidence of cholinergic dysfunction in Parkinson's disease (Commentary on Keo et al., 2021)

Eur J Neurosci. 2021 Jun;53(11):3740-3742. doi: 10.1111/ejn.15269. Epub 2021 May 14.

Authors

Angeliki Zarkali¹, Rimona S Weil^{1

2

3}

Affiliations

¹ Dementia Research Centre, University College London, London, UK.
² Wellcome Centre for Human Neuroimaging, University College London, London, UK.
³ Movement Disorders Consortium, National Hospital for Neurology and Neurosurgery, London, UK.

PMID: 33960522
DOI: 10.1111/ejn.15269

No abstract available

Keywords: Parkinson's disease; neuroimaging; regional gene expression.

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cholinergic Agents
Dopamine
Humans
Parkinson Disease*

Substances

Cholinergic Agents
Dopamine

Grants and funding